W
Walter Berger
Researcher at Medical University of Vienna
Publications - 396
Citations - 16667
Walter Berger is an academic researcher from Medical University of Vienna. The author has contributed to research in topics: Cancer & Cell culture. The author has an hindex of 63, co-authored 359 publications receiving 14045 citations. Previous affiliations of Walter Berger include University of Vienna & Université libre de Bruxelles.
Papers
More filters
Journal ArticleDOI
Specific antioxidant compounds differentially modulate cytotoxic activity of doxorubicin and cisplatin: in vitro and in vivo study.
R. R. Panchuk,N. R. Skorokhyd,V. V. Chumak,L. V. Lehka,S. Omelyanchik,Valery A. Gurinovich,Andrey G. Moiseenok,Petra Heffeter,Walter Berger,Rostyslav Stoika +9 more
TL;DR: Protective effect of specific antioxidant agents during cytotoxic action of doxorubicin was demonstrated in vitro in drug-sensitive human tumor cells and in adult male Wistar rats, while there was no protective effect indrug-resistant sub-lines of these tumor cells during action ofDoxorUBicin and cisplatin.
Journal ArticleDOI
Nanoformulations of anticancer FGFR inhibitors with improved therapeutic index.
Sebastian Kallus,Bernhard Englinger,Julia Senkiv,Anna Laemmerer,Petra Heffeter,Walter Berger,Christian R. Kowol,Bernhard K. Keppler +7 more
TL;DR: In an FGFR inhibitor-sensitive murine osteosarcoma transplantation model (K7M2), only liposomal but not free ponatinib resulted in significant tumor growth inhibition (by 60.4%) at markedly reduced side effects.
Journal ArticleDOI
Fibroblast growth factor receptor 4 induced resistance to radiation therapy in colorectal cancer.
Mohamed A. Ahmed,Edgar Selzer,Wolfgang Dörr,Gerd Jomrich,Felix Harpain,Gerd R. Silberhumer,Leonhard Müllauer,Klaus Holzmann,Bettina Grasl-Kraupp,Michael Grusch,Walter Berger,Brigitte Marian +11 more
TL;DR: FGFR4 may serve as a predictive marker to select CRC patients with MMR-proficient tumors who may benefit from pre-operative radiotherapy by analyzing its levels in rectal tumors of patients with different responses to the therapy.
Journal ArticleDOI
The major vault protein mediates resistance to epidermal growth factor receptor inhibition in human hepatoma cells.
Annemarie Losert,Daniela Lötsch,Andreas Lackner,Herwig Koppensteiner,Barbara Peter-Vörösmarty,Elisabeth Steiner,Klaus Holzmann,Thomas W. Grunt,Katharina Schmid,Brigitte Marian,Bettina Grasl-Kraupp,Rolf Schulte-Hermann,Georg Krupitza,Walter Berger,Michael Grusch +14 more
TL;DR: Analysis of factors connected to the resistance of HCC cells against gefitinib suggest MVP as a novel player in resistance against EGFR inhibition.
Journal ArticleDOI
Impact of CYP24A1 overexpression on growth of colorectal tumour xenografts in mice fed with vitamin D and soy
Julia Höbaus,Samawansha Tennakoon,Petra Heffeter,Charlotte Groeschel,Abhishek Aggarwal,Doris M. Hummel,Ursula Thiem,Rodrig Marculescu,Walter Berger,Enikö Kállay +9 more
TL;DR: It is demonstrated that CYP24A1 overexpression results in increased aggressiveness and proliferative potential of colorectal tumours and combination of vitamin D3 and soy could have an anti‐tumourigenic effect only if CYP 24A1 levels are normal.